New Issue: Orbital Catastrophe Ahead? Read Now

2015 Nobel Prize in Physiology or Medicine

The 2015 Nobel Prize in Physiology or Medicine goes jointly to William C. Campbell and Satoshi Ōmura for their studies leading to novel therapies against infections caused by roundworm parasites and to Youyou Tu for her work developing a novel therapy against malaria

 

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!

“The Nobel Assembly at the Karolinska Institute has today awarded the 2015 Nobel Prize in Physiology or Medicine, with one half jointly to William C. Campbell and Satoshi Ōmura for their discoveries concerning a novel therapy against infections caused by roundworm parasites and the other half to Youyou Tu for her discoveries concerning a novel therapy against malaria.”

Urban Lendahl of the Nobel Committee shortly after 5:30 this morning Eastern time.

Campbell is affiliated with Drew University in New Jersey. Ōmura is at Japan’s Kitasato University. Their work developed the drug Avermectin and later the closely related drug Ivermectin. The medications have led to the near eradication of the roundworm-caused diseases River Blindness and Lymphatic Filariasis, also known as Elephantiasis.


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


Youyou Tu is with the Academy of Chinese Medicine. Her studies led to the creation of the drug Artemisinin, which has lowered mortality rates from malaria. About half the world’s population have been living with the threat of these infections. Both types of drugs are examples of natural products chemistry—that is, the efficacious compounds were isolated from organisms that naturally produce them or similar molecules and had exhibited therapeutic potential in screenings.

“The impact of Avermectin and Artemisinin goes far beyond reducing the disease burden of individuals.” Hans Forssberg of the Nobel Committee.

“By allowing children to go to school and adults to go to work, the treatment helps them to escape poverty, which also contributes to economic growth of the community. The discoveries of the 2015 Nobel Laureates represent a paradigm shift in medicine, which has not only provided revolutionary therapies for patients suffering from devastating parasitic diseases, but has also promoted well-being and prosperity for both individuals and society. The global impact of their discovery and the resulting benefit to mankind is immeasurable.”

For an in-depth listen about the 2015 Nobel Prize in Physiology or Medicine, look for the Scientific American Science Talk podcast later today.

—Steve Mirsky

(The above text is a transcript of this podcast)

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe